Lenox Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Lenox Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$1K	–	1025
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	935
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	699
2021 Q2	$1K	Sell	4 -4	-50%	-$1.32K	﹤0.01%	682
2021 Q1	$3K	Hold	8	–	–	﹤0.01%	584
2020 Q4	$2K	Buy	+8	New	+$2.2K	﹤0.01%	584

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Lenox Wealth Advisors's ONC Position: Q1 2022 in Review

Lenox Wealth Advisors sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 4 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in ONC in Q4 2020 and held it in 5 quarters. The position peaked at $3K in Q1 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

Lenox Wealth Advisors reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
Lenox Wealth Advisors sold 4 BeOne Medicines Ltd shares in Q1 2022, an estimated $1K.
Lenox Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 5 quarters.
Lenox Wealth Advisors's BeOne Medicines Ltd position peaked at $3K in Q1 2021.
239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.